Publications by authors named "Dima Shlon"
Article Synopsis
- The study investigates the effects of GLP-1 analogs, commonly used for diabetes and obesity, on patients with inflammatory bowel diseases (IBD).
- Data was collected from over 3,700 patients with both IBD and diabetes, revealing that those treated with GLP-1 analogs had better health outcomes, reducing the risk of complications.
- The findings highlight a stronger protective effect in obese patients compared to non-obese patients, suggesting a need for further research on mechanisms and broader applicability of GLP-1 analogs.
BACKGROUND Positron emission tomography/computed tomography (PET/CT) has become one of the most prominent modalities worldwide for the diagnosis and surveillance of malignancies. Current clinical imaging guidelines report adverse reactions following PET/CT, especially due to contrast-induced toxicities, such as contrast-induced nephropathy and other rare reactions attributed to a hypersensitivity immune response, such as bronchospasm. Other rare lung toxicities were reported in a few case reports.
View Article and Find Full Text PDF